Kuwatsuka, Yachiyo http://orcid.org/0000-0001-6092-3948
Atsuta, Yoshiko
Hirakawa, Akihiro
Uchida, Naoyuki
Inamoto, Yoshihiro
Najima, Yuho
Ikegame, Kazuhiro
Eto, Tetsuya
Ozawa, Yukiyasu
Ichinohe, Tatsuo
Inoue, Masami
Kimura, Takafumi
Okamoto, Shinichiro
Miyamura, Koichi
Fukuda, Takahiro
Funding for this research was provided by:
Japan Society for the Promotion of Science (26860346, 17K08911)
Article History
Received: 19 May 2020
Revised: 20 July 2020
Accepted: 5 August 2020
First Online: 1 September 2020
Compliance with ethical standards
:
: YK reports grants from Japan Society for the Promotion of Science, during the conduct of the study; YA reports personal fees from Astellas Pharma Inc., Mochida Pharmaceutical Co., Ltd., Meiji Seika Pharma Co, Ltd., CHUGAI PHARMACEUTICAL CO., LTD., Kyowa Kirin Co., Ltd, Janssen Pharmaceutical K.K., outside the submitted work; AH reports grants and personal fees from Ono Pharmaceutical, personal fees from Astellas Pharma, Abbvie, Nippon Boehringer Ingelheim, Kissei Pharmaceutical, Pfizer, Nippon Shinyaku, Chugai Pharmaceutical, Taiho Pharmaceutical, Torii Pharmaceutical, Sumitomo Dainippon Pharma, Teijin Pharma, Fuji Pharma, Japan Tabacco, HEALIOS K.K, Life Science Institute, Inc., Novartis Japan, outside the submitted work; NU reports and personal fees from Chugai Pharmaceutical Co., Ltd., Astellas Pharma Inc., Otsuka Pharmaceeutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., and Novartis Pharma Inc, outside the submitted work; YI reports personal fees from Kyowa Kirin Co., Ltd, Astellas Pharma Inc., Sumitomo Dainippon Pharma Co., Ltd., Novartis, outside the submitted work; YN received personal fees from Pfizer; YO reports personal fees from Pfizer Japan, Astellas Pharma, Novartis Pharma, Kyowa Hakko Kirin, outside the submitted work; TI reports grants from Chugai Pharmaceutical Co., Pfizer, Astellas Pharma, Zenyaku Kogyo Co., and personal fees from Novartis, outside the submitted work; SO reports grants from Asahi Kasei Pharma, Astellas, Eisai, Otsuka, Ono, Kyowa Kirin, Sanofi, Shionogi, Daiichi Sankyo, Takeda, Dainihon Sumitomo, Chugai, Teijin Pharma, Novartis, Mochida, JCR Pharma, Pfizer, personal fees from Astellas, Eisai, Otsuka, Ono, Kyowa Kirin, Sanofi, Daiichi Sankyo, Takeda, Chugai, Nihon Shinyaku, Novartis, BMS, Mochida, JCR Pharma, Pfizer, outside the submitted work; KM reports personal fees from Bristol-Myers Squibb, Novartis, Pfizer, Otsuka, Takeda, Kyowa-Hakko Kirin, Chugai, Astellas Pharmaceuticals, Celgene, Daiichi-Sankyo, Mochida, outside the submitted work. The other authors declare no competing financial interests regarding this paper.